NEW YORK, July 30, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Orthofix International N.V. (NASDAQ: OFIX) ("Orthofix " or the "Company") who purchased Orthofix common stock between July 26, 2012 and July 29, 2013 (the "Class Period"). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 237.
The investigation concerns whether Orthofix and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On July 29, 2013, Orthofix announced that it has delayed the filing of its second quarter 2013 10-Q after revenue recognition issues were identified by the Company's Audit Committee. Additionally, the Company announced that it may need to restate its financial results from prior periods. On this news, the shares of Orthofix fell $4.72, or 17.12% percent, to $22.68 in intraday trading on July 30, 2013.
The Pomerantz Firm, with offices in New York, Chicago, San Diego and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
CONTACT: Robert S. Willoughby Pomerantz Grossman Hufford Dahlstrom & Gross LLP firstname.lastname@example.org
SOURCE Pomerantz Grossman Hufford Dahlstrom & Gross LLP